Sage Journals: Discover world-class research

Abstract

Epidemiological studies, which can have inherent methodological limitations, are used to study the relation between endocrine disrupting chemicals and autism spectrum disorder. The objective is to systematically review the treatment of methodological limitations and assess the quality and strength of the findings in the available literature. The quality and strength of the evidence were evaluated using the Navigation Guide Systematic Review Methodology. The overall quality and strength of the available studies were “moderate” and “limited,” respectively. Risk of bias due to the methodological limitations regarding the exclusion of potential confounding factors and the lack of accuracy of exposure assessment methods were the most prevalent and were also considered to arrive at these results. The omnipresence of endocrine disrupting chemicals, their persistence and bioaccumulation, and the biological plausibility of the association between prenatal exposure to these and later development of autism spectrum disorder highlight the need to carry out well-designed epidemiological studies that overcome the methodological limitations observed in the currently available literature in order to be able to inform public policy to prevent exposure to these potentially harmful chemicals.

Lay abstract

Autism spectrum disorders comprise a complex group with many subtypes of behaviorally defined neurodevelopmental abnormalities in two core areas: deficits in social communication and fixated, restricted, repetitive, or stereotyped behaviors and interests each with potential unique risk factors and characteristics. The underlying mechanisms and the possible causes of autism spectrum disorder remain elusive and while increased prevalence is undoubtable, it is unclear if it is a reflection of diagnostic improvement or emerging risk factors such as endocrine disrupting chemicals. Epidemiological studies, which are used to study the relation between endocrine disrupting chemicals and autism spectrum disorder, can have inherent methodological challenges that limit the quality and strength of their findings. The objective of this work is to systematically review the treatment of these challenges and assess the quality and strength of the findings in the currently available literature. The overall quality and strength were “moderate” and “limited,” respectively. Risk of bias due to the exclusion of potential confounding factors and the lack of accuracy of exposure assessment methods were the most prevalent. The omnipresence of endocrine disrupting chemicals and the biological plausibility of the association between prenatal exposure and later development of autism spectrum disorder highlight the need to carry out well-designed epidemiological studies that overcome the methodological challenges observed in the currently available literature in order to be able to inform public policy to prevent exposure to these potentially harmful chemicals and aid in the establishment of predictor variables to facilitate early diagnosis of autism spectrum disorder and improve long-term outcomes.

Keywords

autism spectrum disorder developmental neurotoxicants endocrine disrupting chemicals prenatal exposure

Get full access to this article

View all access options for this article.

References

Ahel

McEvoy

Giger

(1993). Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environmental Pollution, 79(3), 243–248.

Alkemade

(2015). Thyroid hormone and the developing hypothalamus. Frontiers in Neuroanatomy, 9, Article 15.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. DSM-V.

Andersen

Laurberg

Olsen

(2014). Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: A Danish nationwide cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 121(11), 1365–1374.

Anway

M. D.

Cupp

A. S.

Uzumcu

Skinner

M. K.

(2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science, 308(5727), 1466–1469. https://doi.org/308/5727/1466

Anway

M. D.

Skinner

M. K.

(2008). Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease. The Prostate, 68(5), 517–529.

Asperger

(1944). Die “Autistischen psychopathen” im kindesalter. European Archives of Psychiatry and Clinical Neuroscience, 117(1), 76–136.

Atladóttir

H. Ó.

Thorsen

Østergaard

Schendel

D. E.

Lemcke

Abdallah

Parner

E. T.

(2010). Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. Journal of Autism and Developmental Disorders, 40(12), 1423–1430.

Auyeung

Taylor

Hackett

Baron-Cohen

(2010). Foetal testosterone and autistic traits in 18 to 24-month-old children. Molecular Autism, 1(1), Article 11.

10.

Balshem

Helfand

Schünemann

H. J.

Oxman

A. D.

Kunz

Brozek

. . . Guyatt

G. H.

(2011). GRADE guidelines: 3. rating the quality of evidence. Journal of Clinical Epidemiology, 64(4), 401–406. https://doi.org/10.1016/j.jclinepi.2010.07.015

11.

Barker

D. J.

(2012). Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health, 126(3), 185–189. https://doi.org/10.1016/j.puhe.2011.11.014

12.

Baron-Cohen

Auyeung

Nørgaard-Pedersen

Hougaard

D. M.

Abdallah

M. W.

Melgaard

. . . Lombardo

M. V.

(2015). Elevated fetal steroidogenic activity in autism. Molecular Psychiatry, 20(3), 369–376.

13.

Baron-Cohen

Tsompanidis

Auyeung

Nørgaard-Pedersen

Hougaard

D. M.

Abdallah

. . . Pohl

(2020). Foetal oestrogens and autism. Molecular Psychiatry, 25, 2970–2978.

14.

Barouki

Gluckman

P. D.

Grandjean

Hanson

Heindel

J. J.

(2012). Developmental origins of non-communicable disease: Implications for research and public health. Environmental Health, 11(1), Article 42.

15.

Beausoleil

Ormsby

Gies

Hass

Heindel

J. J.

Holmer

M. L.

. . . Schoenfelder

(2013). Low dose effects and non-monotonic dose responses for endocrine active chemicals: Science to practice workshop: Workshop summary. Chemosphere, 93(6), 847–856.

16.

Berko

E. R.

Suzuki

Beren

Lemetre

Alaimo

C. M.

Calder

R. B.

. . . Kirschen

(2014). Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLOS Genetics, 10(5), Article e1004402.

17.

Beronius

Rudén

Hanberg

Håkansson

(2009). Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union. Regulatory Toxicology and Pharmacology, 55(2), 111–122.

18.

Blackburn

(2009). Maternal-fetal thyroid interactions. The Journal of Perinatal & Neonatal Nursing, 23(4), 312–313.

19.

Bodar

Bruijn

J. D.

Vermeire

Zandt

V. D.

(2002). Trends in risk assessment of chemicals in the European Union. Human and Ecological Risk Assessment, 8(7), 1825–1843.

20.

Braun

J. M.

(2012). Endocrine disrupting compounds, gonadal hormones, and autism. Developmental Medicine & Child Neurology, 54(11), 1068–1068.

21.

Braun

J. M.

Kalkbrenner

A. E.

Just

A. C.

Yolton

Calafat

A. M.

Sjodin

. . . Lanphear

B. P.

(2014). Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: The HOME study. Environmental Health Perspectives, 122(5), 513–520. https://doi.org/10.1289/ehp.1307261

22.

Braun

J. M.

Yolton

Dietrich

K. N.

Hornung

Calafat

A. M.

Lanphear

B. P.

(2009). Prenatal bisphenol A exposure and early childhood behavior. Environmental Health Perspectives, 117(12), 1945–1952. https://doi.org/10.1289/ehp.0900979

23.

Braun

J. M.

Yolton

Stacy

S. L.

Erar

Papandonatos

G. D.

Bellinger

D. C.

. . . Chen

(2017). Prenatal environmental chemical exposures and longitudinal patterns of child neurobehavior. Neurotoxicology, 62, 192–199.

24.

Buescher

A. V.

Cidav

Knapp

Mandell

D. S.

(2014). Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatrics, 168(8), 721–728.

25.

Butt

C. M.

Stapleton

H. M.

(2013). Inhibition of thyroid hormone sulfotransferase activity by brominated flame retardants and halogenated phenolics. Chemical Research in Toxicology, 26(11), 1692–1702.

26.

Büyükgebiz

(2006). Newborn screening for congenital hypothyroidism. Journal of Pediatric Endocrinology and Metabolism, 19(11), 1291–1298.

27.

Campbell

C. G.

Borglin

S. E.

Green

F. B.

Grayson

Wozei

Stringfellow

W. T.

(2006). Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water: A review. Chemosphere, 65(8), 1265–1280.

28.

Cao

Rebuli

M. E.

Rogers

Todd

K. L.

Leyrer

S. M.

Ferguson

S. A.

Patisaul

H. B.

(2013). Prenatal bisphenol A exposure alters sex-specific estrogen receptor expression in the neonatal rat hypothalamus and amygdala. Toxicological Sciences, 133(1), 157–173.

29.

Centers for Disease Control and Prevention). (2007). Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, 6 sites, United States, 2000. Morbidity and Mortality Weekly Report Surveillance Summaries, 56(1), 1–11.

30.

Centers for Disease Control and Prevention). (2012). Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report Surveillance Summaries, 61(3), 1–19.

31.

Centers for Disease Control and Prevention. (2018). Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1

32.

Chang

Choo

Lee

Choi

(2009). The methods of identification, analysis, and removal of endocrine disrupting compounds (EDCs) in water. Journal of Hazardous Materials, 172(1), 1–12.

33.

Cheslack-Postava

Rantakokko

P. V.

Hinkka-Yli-Salomäki

Surcel

McKeague

I. W.

Kiviranta

H. A.

. . . Brown

A. S.

(2013). Maternal serum persistent organic pollutants in the Finnish prenatal study of autism: A pilot study. Neurotoxicology and Teratology, 38, 1–5.

34.

Chevrier

Gunier

R. B.

Bradman

Holland

N. T.

Calafat

A. M.

Eskenazi

Harley

K. G.

(2013). Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environmental Health Perspectives, 121(1), 138–144. https://doi.org/10.1289/ehp.1205092

35.

Choleris

Gustafsson

Korach

Muglia

Pfaff

Ogawa

(2003). An estrogen dependent micronet mediating social recognition: A study with oxytocin-and estrogen receptor α- and β-knockout mice. Proceedings of the National Academy of Sciences, 100, 6192–6197.

36.

Christensen

F. M.

Andersen

Duijm

N. J.

Harremoës

(2003). Risk terminology—A platform for common understanding and better communication. Journal of Hazardous Materials, 103(3), 181–203.

37.

The Cochrane Collaboration. (2011). Cochrane handbook for systematic reviews of interventions. Cochrane book series ( Higgins

Green

, Eds.) (Version 5.1). The Cochrane Collaboration and John Wiley & Sons.

38.

Colvert

Tick

McEwen

Stewart

Curran

S. R.

Woodhouse

. . . Garnett

(2015). Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry, 72(5), 415–423.

39.

Cooney

C. M.

(2000). Science panel confirms low-dose estrogenic effects. Environmental Science & Technology, 34(23), 500A–502A.

40.

Craig

Z. R.

Wang

Flaws

J. A.

(2011). Endocrine-disrupting chemicals in ovarian function: Effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction, 142(5), 633–646. https://doi.org/10.1530/REP-11-0136

41.

Croen

L. A.

Matevia

Yoshida

C. K.

Grether

J. K.

(2008). Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. American Journal of Obstetrics & Gynecology, 199(3), 234.e1–234.e6.

42.

Del-Mazo

Brieno-Enriquez

M. A.

Garcia-Lopez

Lopez-Fernandez

L. A.

De-Felici

(2013). Endocrine disruptors, gene deregulation and male germ cell tumors. The International Journal of Developmental Biology, 57(2–4), 225–239. https://doi.org/10.1387/ijdb.130042jd

43.

Depino

A. M.

(2018). Perinatal inflammation and adult psychopathology: From preclinical models to humans. Seminars in Cell & Developmental Biology, 77, 104–114.

44.

Dickerson

A. S.

Rahbar

M. H.

Bakian

A. V.

Bilder

D. A.

Harrington

R. A.

Pettygrove

. . . Moyé

L. A.

(2016). Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environmental Monitoring and Assessment, 188(7), Article 407.

45.

Dietert

R. R.

(2014). Transgenerational epigenetics of endocrine-disrupting chemicals. In Tollefsbol

(Ed.), Transgenerational epigenetics (pp. 239–254). Academic Press. https://doi.org/10.1016/B978-0-12-405944-3.00018-0

46.

Domínguez-Romero

Scheringer

(2019). A review of phthalate pharmacokinetics in human and rat: What factors drive phthalate distribution and partitioning? Drug Metabolism Reviews, 51(3), 314–329. https://doi.org/10.1080/03602532.2019.1620762

47.

Eertmans

Dhooge

Stuyvaert

Comhaire

(2003). Endocrine disruptors: Effects on male fertility and screening tools for their assessment. Toxicology in Vitro, 17(5–6), 515–524.

48.

Environmental Health Standing Committee (enHealth). (2002). Environmental health risk assessment. Guidelines for assessing human health risks from environmental hazards. Australian Department of Health.

49.

European Commission Joint Research Center, Institute for Health and Consumer Protection, & European Chemicals Bureau. (2003). Technical guidance document on risk assessment. European Commission.

50.

European Food Safety Authority. (2010). Scientific report of the endocrine active substances task force. EFSA Journal, 8(11), 1932–1991.

51.

European Food Safety Authority Scientific Committee. (2013). Scientific opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA Journal, 11(3), 3132–3215.

52.

Frazier

T. W.

Thompson

Youngstrom

E. A.

Law

Hardan

A. Y.

Eng

Morris

(2014). A twin study of heritable and shared environmental contributions to autism. Journal of Autism and Developmental Disorders, 44(8), 2013–2025.

53.

Freire

Ramos

Amaya

Fernández

M. F.

Santiago-Fernández

Lopez-Espinosa

. . . Olea

(2010). Newborn TSH concentration and its association with cognitive development in healthy boys. European Journal of Endocrinology, 163(6), 901–909.

54.

Friedenreich

C. M.

(1993). Methods for pooled analyses of epidemiologic studies. Epidemiology, 4(4), 295–302.

55.

Froom

(1993). Presentation deficiencies in structured medical abstracts. Journal of Clinical Epidemiology, 46(7), 591–594.

56.

Fuhrman

V. F.

Tal

Arnon

(2015). Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond. Journal of Hazardous Materials, 286, 589–611.

57.

Gee

(2008). Establishing evidence for early action: The prevention of reproductive and developmental harm. Basic & Clinical Pharmacology & Toxicology, 102(2), 257–266.

58.

Geier

D. A.

Kern

J. K.

Geier

M. R.

(2009). A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. Acta Neurobiologiae Experimentalis, 69(2), 189–197.

59.

Geier

D. A.

Mumper

Gladfelter

Coleman

Geier

M. R.

(2008). Neurodevelopmental disorders, maternal Rh-negativity, and Rho (D) immune globulins: A multi-center assessment. Neuroendocrinology Letters, 29(2), Article 272.

60.

Gendre

Lafontaine

Delsaut

Simon

(2004). Exposure to polycyclic aromatic hydrocarbons and excretion of urinary 3-hydroxybenzo[A] pyrene: Assessment of an appropriate sampling time. Polycyclic Aromatic Compounds, 24(4–5), 433–439. https://doi.org/10.1080/10406630490468766

61.

Ghosh

Mitra

P. S.

Loffredo

C. A.

Trnovec

Murinova

Sovcikova

. . . Dutta

S. K.

(2015). Transcriptional profiling and biological pathway analysis of human equivalence PCB exposure in vitro: Indicator of disease and disorder development in humans. Environmental Research, 138, 202–216.

62.

Gillberg

I. C.

Gillberg

Kopp

(1992). Hypothyroidism and autism spectrum disorders. Journal of Child Psychology and Psychiatry, 33(3), 531–542.

63.

Gore

A. C.

Chappell

Fenton

Flaws

J. A.

Nadal

Prins

. . . Zoeller

(2015). EDC-2: The endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews, 36(6), E1–E150.

64.

Greally

J. M.

Jacobs

M. N.

(2013). In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors. ALTEX—Alternatives to Animal Experimentation, 30(4), 445–471.

65.

Greene

Goeden

Rice

Shubat

(2012). Apportionment of exposure and risk from contaminants of emerging concern (2012 Annual Meeting: Advancing Analysis ed.). Society for Risk Analysis (SRA).

66.

Guyatt

G. H.

Oxman

A. D.

Akl

E. A.

Kunz

Vist

Brozek

. . . Schünemann

H. J.

(2011). GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64(4), 383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026

67.

Guyatt

G. H.

Oxman

A. D.

Kunz

Atkins

Brozek

Vist

. . . Schunemann

H. J.

(2011). GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology, 64(4), 395–400. https://doi.org/10.1016/j.jclinepi.2010.09.012

68.

Guyatt

G. H.

Oxman

A. D.

Vist

Kunz

Brozek

Alonso-Coello

. . . Schünemann

H. J.

(2011). GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias). Journal of Clinical Epidemiology, 64(4), 407–415. https://doi.org/10.1016/j.jclinepi.2010.07.017

69.

Guzick

D. S.

Swan

(2006). The decline of infertility: Apparent or real? Fertility and Sterility, 86(3), 524–526.

70.

Haddow

J. E.

Palomaki

G. E.

Allan

W. C.

Williams

J. R.

Knight

G. J.

Gagnon

. . . Waisbren

S. E.

(1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine, 341(8), 549–555.

71.

Hamers

Kamstra

J. H.

Cenijn

P. H.

Pencikova

Palkova

Simeckova

. . . Machala

(2011). In vitro toxicity profiling of ultrapure non–dioxin-like polychlorinated biphenyl congeners and their relative toxic contribution to PCB mixtures in humans. Toxicological Sciences, 121(1), 88–100.

72.

Hecker

Hollert

(2011). Endocrine disruptor screening: Regulatory perspectives and needs. Environmental Sciences Europe, 23(1), Article 15.

73.

Heindel

J. J.

Balbus

Birnbaum

Brune-Drisse

M. N.

Grandjean

Gray

. . . Slechta

D. C.

(2016). Developmental origins of health and disease: Integrating environmental influences. Endocrinology, 2016(1), 17–22.

74.

Heinrichs

von Dawans

Domes

(2009). Oxytocin, vasopressin, and human social behavior. Frontiers in Neuroendocrinology, 30(4), 548–557.

75.

Henningsson

Jonsson

Ljunggren

Westberg

Gillberg

Råstam

. . . Thuresson

(2009). Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology, 34(5), 752–761.

76.

Herbstman

J. B.

Sjodin

Kurzon

Lederman

S. A.

Jones

R. S.

Rauh

. . . Perera

(2010). Prenatal exposure to PBDEs and neurodevelopment. Environmental Health Perspectives, 118(5), 712–719. https://doi.org/10.1289/ehp.0901340

77.

Hollander

Bartz

Chaplin

Phillips

Sumner

Soorya

. . . Wasserman

(2007). Oxytocin increases retention of social cognition in autism. Biological Psychiatry, 61(4), 498–503.

78.

Hollander

Novotny

Hanratty

Yaffe

DeCaria

C. M.

Aronowitz

B. R.

Mosovich

(2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology, 28(1), 193–198.

79.

Hönekopp

(2011). Relationships between digit ratio 2D: 4D and self-reported aggression and risk taking in an online study. Personality and Individual Differences, 51(1), 77–80.

80.

Hönekopp

Bartholdt

Beier

Liebert

(2007). Second to fourth digit length ratio (2D: 4D) and adult sex hormone levels: New data and a meta-analytic review. Psychoneuroendocrinology, 32(4), 313–321.

81.

Hooper

S. W.

Pettigrew

C. A.

Sayler

G. S.

(1990). Ecological fate, effects and prospects for the elimination of environmental polychlorinated biphenyls (PCBs). Environmental Toxicology and Chemistry: An International Journal, 9(5), 655–667.

82.

Horlin

Falkmer

Parsons

Albrecht

M. A.

Falkmer

(2014). The cost of autism spectrum disorders. PLOS ONE, 9(9), Article e106552.

83.

Jin

Wan

Yang

Tao

(2005). Trophodynamic behavior of 4-nonylphenol and nonylphenol polyethoxylate in a marine aquatic food web from Bohai Bay, North China: Comparison to DDTs. Environmental Science & Technology, 39(13), 4801–4807.

84.

Huang

Phillips

J. R.

Hunter

L. D.

(2007). Human exposure to medicinal, dietary, and environmental estrogens. Toxicological & Environmental Chemistry, 89(1), 141–160.

85.

Ingudomnukul

Baron-Cohen

Wheelwright

Knickmeyer

(2007). Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Hormones and Behavior, 51(5), 597–604.

86.

International Agency for Research on Cancer. (2006). IARC monographs on the evaluation of carcinogenic risks to humans: Preamble. World Health Organization. https://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf

87.

Hong

Kho

Choi

(2013). Effects of bisphenol S exposure on endocrine functions and reproduction of zebrafish. Environmental Science & Technology, 47(15), 8793–8800.

88.

Johns

L. E.

Ferguson

K. K.

Soldin

O. P.

Cantonwine

D. E.

Rivera-González

L. O.

Del Toro

L. V. A.

. . . Cordero

J. F.

(2015). Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: A longitudinal analysis. Reproductive Biology and Endocrinology, 13(1), Article 4.

89.

Johnson

Koustas

Vesterinen

Sutton

Atchley

Kim

. . . Bero

(2016). Application of the navigation guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environment International, 92, 716–728.

90.

Johnson

Sutton

Atchley

Koustas

Lam

Sen

. . . Woodruff

(2014). The navigation guide—Evidence-based medicine meets environmental health: Systematic review of human evidence for PFOA effects on fetal growth. Environmental Health Perspectives, 122(10), 1028–1039. https://doi.org/10.1289/ehp.1307893

91.

Kalkbrenner

A. E.

Daniels

J. L.

Chen

J. C.

Poole

Emch

Morrissey

(2010). Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology, 21(5), 631–641. https://doi.org/10.1097/EDE.0b013e3181e65d76

92.

Kanner

(1968). Autistic disturbances of affective contact. Acta Paedopsychiatrica, 35(4), 100–136.

93.

Khan

Harney

Zavacki

Sajdel-Sulkowska

(2014). Disrupted brain thyroid hormone homeostasis and altered thyroid hormone-dependent brain gene expression in autism spectrum disorders. Journal of Physiology and Pharmacology, 65(2), 257–272.

94.

Kim

S. M.

Han

D. H.

Lyoo

H. S.

Min

K. J.

Kim

K. H.

Renshaw

(2010). Exposure to environmental toxins in mothers of children with autism spectrum disorder. Psychiatry Investigation, 7(2), 122–127.

95.

Kim

E. H.

Kim

E. J.

Park

Kim

J. H.

. . . Kim

B. N.

(2011). Prenatal exposure to phthalates and infant development at 6 months: Prospective mothers and children’s environmental health (MOCEH) study. Environmental Health Perspectives, 119(10), 1495–1500. https://doi.org/10.1289/ehp.1003178

96.

Knez

(2013). Endocrine-disrupting chemicals and male reproductive health. Reproductive Biomedicine Online, 26(5), 440–448.

97.

Kolpin

D. W.

Furlong

E. T.

Meyer

M. T.

Thurman

E. M.

Zaugg

S. D.

Barber

L. B.

Buxton

H. T.

(2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: A national reconnaissance. Environmental Science & Technology, 36(6), 1202–1211.

98.

Kortenkamp

(2008). Low dose mixture effects of endocrine disrupters: Implications for risk assessment and epidemiology. International Journal of Andrology, 31(2), 233–240.

99.

Kortenkamp

Backhaus

Faust

(2009). State of the art report on mixture toxicity. Contract, 70307(2007485103), 94–103.

100.

Koustas

Lam

Sutton

Johnson

P. I.

Atchley

D. S.

Sen

. . . Woodruff

T. J.

(2014). The navigation guide—Evidence-based medicine meets environmental health: Systematic review of nonhuman evidence for PFOA effects on fetal growth. Environmental Health Perspectives, 122(10), 1015–1027. https://doi.org/10.1289/ehp.1307177

101.

Kutz

F. W.

Wood

P. H.

Bottimore

D. P.

(1991). Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Reviews of Environmental Contamination and Toxicology, 120, 1–82).

102.

Lagarde

Beausoleil

Belcher

S. M.

Belzunces

L. P.

Emond

Guerbet

Rousselle

(2015). Non-monotonic dose-response relationships and endocrine disruptors: A qualitative method of assessment. Environmental Health, 14(1), Article 13.

103.

Lai

M. C.

Lombardo

M. V.

Baron-Cohen

(2014). Autism. Lancet, 383(9920), 896–910. https://doi.org/10.1016/S0140-6736(13)61539-1

104.

Lam

Sutton

Halladay

Davidson

L. I.

Lawler

Newschaffer

C. J.

. . . Woodruff

T. J.

(2015). Applying the navigation guide systematic review methodology case study #4. Association between developmental exposures to ambient air pollution and autism. A systematic review of the evidence protocol. PROSPERO: International Prospective Register of Systematic Reviews. http://www.crd.york.ac.uk/PROSPEROFILES/17890_PROTOCOL_20150226.pdf

105.

Lam

Sutton

Kalkbrenner

Windham

Halladay

Koustas

. . . Newschaffer

(2016). A systematic review and meta-analysis of multiple airborne pollutants and autism spectrum disorder. PLOS ONE, 11(9), Article e0161851.

106.

Lange

Paull

G. C.

Coe

T. S.

Katsu

Urushitani

Iguchi

Tyler

C. R.

(2009). Sexual reprogramming and estrogenic sensitization in wild fish exposed to ethinylestradiol. Environmental Science & Technology, 43(4), 1219–1225.

107.

Larsson

Weiss

Janson

Sundell

Bornehag

(2009). Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of age. Neurotoxicology, 30(5), 822–831.

108.

Lee

(2018). Evidence of the possible harm of endocrine-disrupting chemicals in humans: Ongoing debates and key issues. Endocrinology and Metabolism, 33(1), 44–52.

109.

Lee

Jacobs

D. R.

(2015). Methodological issues in human studies of endocrine disrupting chemicals. Reviews in Endocrine and Metabolic Disorders, 16(4), 289–297.

110.

Romanoff

Bartell

Pittman

E. N.

Trinidad

D. A.

McClean

. . . Sjödin

(2012). Excretion profiles and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. Chemical Research in Toxicology, 25(7), 1452–1461. https://doi.org/10.1021/tx300108e

111.

Liberati

Altman

D. G.

Tetzlaff

Mulrow

Gøtzsche

P. C.

Ioannidis

J. P.

. . . Moher

(2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLOS Medicine, 6(7), Article e1000100.

112.

Liebig

Egeler

Oehlmann

Knacker

(2005). Bioaccumulation of 14C-17α-ethinylestradiol by the aquatic oligochaete lumbriculus variegatus in spiked artificial sediment. Chemosphere, 59(2), 271–280.

113.

Liew

Ritz

von Ehrenstein

O. S.

Bech

B. H.

Nohr

E. A.

Fei

. . . Olsen

(2015). Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: A nested case-control study in the Danish national birth cohort. Environmental Health Perspectives, 123(4), 367–373. https://doi.org/10.1289/ehp.1408412

114.

Liu

Wang

Huang

Lin

Zhou

Pan

(2012). Biological effects and bioaccumulation of steroidal and phenolic endocrine disrupting chemicals in high-back crucian carp exposed to wastewater treatment plant effluents. Environmental Pollution, 162, 325–331.

115.

Lyall

Croen

L. A.

Sjodin

Yoshida

C. K.

Zerbo

Kharrazi

Windham

G. C.

(2017). Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: Association with autism spectrum disorder and intellectual disability. Environmental Health Perspectives, 125(3), 474–480. https://doi.org/10.1289/EHP277

116.

Manikkam

Guerrero-Bosagna

Tracey

Haque

M. M.

Skinner

M. K.

(2012). Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures. PLOS ONE, 7(2), Article e31901.

117.

Marques-Pinto

Carvalho

(2013). Human infertility: Are endocrine disruptors to blame? Endocrine Connections, 2(3), R15–R29.

118.

Martin

O. V.

Lester

J. N.

Voulvoulis

Boobis

A. R.

(2007). Human health and endocrine disruption: A simple multicriteria framework for the qualitative assessment of end point–specific risks in a context of scientific uncertainty. Toxicological Sciences, 98(2), 332–347.

119.

Matson

J. L.

(2007). Current status of differential diagnosis for children with autism spectrum disorders. Research in Developmental Disabilities, 28(2), 109–118.

120.

McCanlies

E. C.

Fekedulegn

Mnatsakanova

Burchfiel

C. M.

Sanderson

W. T.

Charles

L. E.

Hertz-Picciotto

(2012). Parental occupational exposures and autism spectrum disorder. Journal of Autism and Developmental Disorders, 42(11), 2323–2334.

121.

Meerts

I. A.

Assink

Cenijn

P. H.

Van den Berg

J. H. J.

Weijers

B. M.

Bergman

Å.

. . . Brouwer

(2002). Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat. Toxicological Sciences, 68(2), 361–371.

122.

Miles

J. H.

Takahashi

T. N.

(2007). Lack of association between Rh status, Rh immune globulin in pregnancy and autism. American Journal of Medical Genetics Part A, 143(13), 1397–1407.

123.

Miodovnik

Engel

S. M.

Zhu

Soorya

L. V.

Silva

M. J.

. . . Wolff

M. S.

(2011). Endocrine disruptors and childhood social impairment. Neurotoxicology, 32(2), 261–267.

124.

Modahl

Green

L. A.

Fein

Morris

Waterhouse

Feinstein

Levin

(1998). Plasma oxytocin levels in autistic children. Biological Psychiatry, 43(4), 270–277.

125.

Moore

S. J.

Turnpenny

Quinn

Glover

Lloyd

D. J.

Montgomery

Dean

J. C.

(2000). A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics, 37(7), 489–497. https://doi.org/10.1136/jmg.37.7.489

126.

Morgan

R. L.

Whaley

Thayer

K. A.

Schunemann

H. J.

(2018). Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environment International, 121(Pt. 1), 1027–1031. https://doi.org/S0160-4120(18)30204-6 [pii]

127.

Moriyama

Tagami

Akamizu

Usui

Saijo

Kanamoto

. . . Nakao

(2002). Thyroid hormone action is disrupted by bisphenol A as an antagonist. The Journal of Clinical Endocrinology & Metabolism, 87(11), 5185–5190.

128.

Morreale de Escobar

(2001). The role of thyroid hormone in fetal neurodevelopment. Journal of Pediatric Endocrinology and Metabolism, 14(Suppl. 6), 1453–1462.

129.

Morreale De Escobar

Obregón

Escobar Del Rey

(2004). Role of thyroid hormone during early brain development. European Journal of Endocrinology, 151(Suppl_3), U25–U37.

130.

Motorykin

Santiago-Delgado

Rohlman

Schrlau

J. E.

Harper

Harris

. . . Massey Simonich

S. L.

(2015). Metabolism and excretion rates of parent and hydroxy-PAHs in urine collected after consumption of traditionally smoked salmon for native American volunteers. The Science of the Total Environment, 514, 170–177. https://doi.org/10.1016/j.scitotenv.2015.01.083

131.

Natural Resource Management Ministerial Council, Environment Protection and Heritage Council, & National Health and Medical Research Council. (2008). National water quality management strategy: Australian guidelines for water recycling: Managing health and environmental risks (phase 2)—augmentation of drinking water. Biotext Pty Ltd.

132.

Newbold

R. R.

Padilla-Banks

Jefferson

W. N.

(2006). Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology, 147(6), s11–s17.

133.

Nicolini

Fahnestock

(2018). The valproic acid-induced rodent model of autism. Experimental Neurology, 299, 217–227.

134.

Nishimura

Miyabara

Sato

Yonemoto

Tohyama

(2002). Immunohistochemical localization of thyroid stimulating hormone induced by a low oral dose of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in female Sprague–Dawley rats. Toxicology, 171(2–3), 73–82.

135.

Norstrom

Hallett

Sonstegard

(1978). Coho salmon (Oncorhynchus kisutch) and herring gulls (Larus argentatus) as indicators of organochlorine contamination in Lake Ontario. Journal of the Fisheries Board of Canada, 35(11), 1401–1409.

136.

Nowack

Wittsiepe

Kasper-Sonnenberg

Wilhelm

Schölmerich

(2015). Influence of low-level prenatal exposure to PCDD/Fs and PCBs on empathizing, systemizing and autistic traits: Results from the Duisburg birth cohort study. PLOS ONE, 10(6), Article e0129906.

137.

Noyes

P. D.

Lema

S. C.

Macaulay

L. J.

Douglas

N. K.

Stapleton

H. M.

(2013). Low level exposure to the flame retardant BDE-209 reduces thyroid hormone levels and disrupts thyroid signaling in fathead minnows. Environmental Science & Technology, 47(17), 10012–10021.

138.

Ousley

Cermak

(2014). Autism spectrum disorder: Defining dimensions and subgroups. Current Developmental Disorders Reports, 1(1), 20–28.

139.

Pemberton

H. N.

Franklyn

J. A.

Kilby

M. D.

(2005). Thyroid hormones and fetal brain development. Minerva Ginecologica, 57(4), 367–378.

140.

Pino-López

Romero-Ayuso

D. M.

(2013). Trastornos del espectro autista y exposiciones ocupacionales de los progenitores. Revista Española De Salud Pública, 87, 73–85.

141.

Price

C. S.

Thompson

W. W.

Goodson

Weintraub

E. S.

Croen

L. A.

Hinrichsen

V. L.

. . . Lewis

(2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656–664.

142.

Rasalam

Hailey

Williams

J. H. G.

Moore

Turnpenny

Lloyd

D. J.

Dean

J. C.

(2005). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine & Child Neurology, 47(8), 551–555.

143.

Roberts

A. L.

Lyall

Hart

J. E.

Laden

Just

A. C.

Bobb

J. F.

. . . Weisskopf

M. G.

(2013). Perinatal air pollutant exposures and autism spectrum disorder in the children of nurses’ health study II participants. Environmental Health Perspectives, 121(8), 978–984. https://doi.org/10.1289/ehp.1206187

144.

Roberts

E. M.

English

P. B.

Grether

J. K.

Windham

G. C.

Somberg

Wolff

(2007). Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environmental Health Perspectives, 115(10), 1482–1489. https://doi.org/10.1289/ehp.10168

145.

Robinson

E. B.

Koenen

K. C.

McCormick

M. C.

Munir

Hallett

Happé

. . . Ronald

(2011). Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%). Archives of General Psychiatry, 68(11), 1113–1121.

146.

Rogge

Janssen

(2019). The economic costs of autism spectrum disorder: A literature review. Journal of Autism and Developmental Disorders, 49, 2873–2900.

147.

Román

G. C.

(2007). Autism: Transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. Journal of the Neurological Sciences, 262(1–2), 15–26.

148.

Rotem

R. S.

Chodick

Shalev

Davidovitch

Koren

Hauser

. . . Weisskopf

M. G.

(2020). Maternal thyroid disorders and risk of autism spectrum disorder in progeny. Epidemiology, 31(3), 409–417.

149.

Rovet

J. F.

(2014). The role of thyroid hormones for brain development and cognitive function. Endocrine Development, 26, 26–43. https://doi.org/10.1159/000363153

150.

Sandin

Lichtenstein

Kuja-Halkola

Larsson

Hultman

C. M.

Reichenberg

(2014). The familial risk of autism. JAMA, 311(17), 1770–1777.

151.

Sawaya

Guirguis-Blake

LeFevre

Harris

Petitti

(2007). Update on methods: Estimating certainty and magnitude of net benefit: US preventive services task force. Annals of Internal Medicine, 147, 871–875.

152.

Schmutzler

Bacinski

Gotthardt

Huhne

Ambrugger

Klammer

. . . Wuttke

(2007). The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology, 148(6), 2835–2844.

153.

Schmutzler

Hamann

Hofmann

P. J.

Kovacs

Stemmler

Mentrup

. . . Seidlova-Wuttke

(2004). Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology, 205(1–2), 95–102.

154.

Schulkin

(2007). Autism and the amygdala: An endocrine hypothesis. Brain and Cognition, 65(1), 87–99.

155.

Shelton

J. F.

Geraghty

E. M.

Tancredi

D. J.

Delwiche

L. D.

Schmidt

R. J.

Ritz

. . . Hertz-Picciotto

(2014). Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: The CHARGE study. Environmental Health Perspectives, 122(10), Article 1103.

156.

Siu

M. T.

Weksberg

(2017). Epigenetics of autism spectrum disorder. In Delgado-Morales

(Ed.), Neuroepigenomics in aging and disease (pp. 63–90). Springer.

157.

Skinner

M. K.

Savenkova

M. I.

Zhang

Gore

A. C.

Crews

(2014). Gene bionetworks involved in the epigenetic transgenerational inheritance of altered mate preference: Environmental epigenetics and evolutionary biology. BMC Genomics, 15(1), Article 377.

158.

Snyder

S. A.

Benotti

M. J.

(2010). Endocrine disruptors and pharmaceuticals: Implications for water sustainability. Water Science and Technology, 61(1), 145–154.

159.

Soto

A. M.

Sonnenschein

Chung

K. L.

Fernandez

M. F.

Olea

Serrano

F. O.

(1995). The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environmental Health Perspectives, 103(Suppl. 7), 113–122. https://doi.org/10.1289/ehp.95103s7113

160.

Stamou

Streifel

K. M.

Goines

P. E.

Lein

P. J.

(2013). Neuronal connectivity as a convergent target of gene×environment interactions that confer risk for autism spectrum disorders. Neurotoxicology and Teratology, 36, 3–16.

161.

St-Hilaire

Ezike

V. O.

Stryhn

Thomas

M. A.

(2012). An ecological study on childhood autism. International Journal of Health Geographics, 11(1), Article 44.

162.

Stoltenberg

Schjølberg

Bresnahan

Hornig

Hirtz

Dahl

. . . Alsaker

(2010). The autism birth cohort: A paradigm for gene–environment–timing research. Molecular Psychiatry, 15(7), 676–680.

163.

Street

Angelini

Bernasconi

Burgio

Cassio

Catellani

. . . Fanos

(2018). Current knowledge on endocrine disrupting chemicals (EDCs) from animal biology to humans, from pregnancy to adulthood: Highlights from a national Italian meeting. International Journal of Molecular Sciences, 19(6), Article 1647.

164.

Surén

Roth

Bresnahan

Haugen

Hornig

Hirtz

. . . Reichborn-Kjennerud

(2013). Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA, 309(6), 570–577.

165.

Svechnikov

Stukenborg

J. B.

Savchuck

Soder

(2014). Similar causes of various reproductive disorders in early life. Asian Journal of Andrology, 16(1), 50–59. https://doi.org/10.4103/1008-682X.122199

166.

Szatmari

Liu

Goldberg

Zwaigenbaum

Paterson

A. D.

Woodbury-Smith

. . . Thompson

(2012). Sex differences in repetitive stereotyped behaviors in autism: Implications for genetic liability. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159(1), 5–12.

167.

Talbott

E. O.

Marshall

L. P.

Rager

J. R.

Arena

V. C.

Sharma

R. K.

Stacy

S. L.

(2015). Air toxics and the risk of autism spectrum disorder: The results of a population based case—Control study in southwestern Pennsylvania. Environmental Health, 14(1), Article 80.

168.

Tareen

R. S.

Kamboj

M. K.

(2012). Role of endocrine factors in autistic spectrum disorders. Pediatric Clinics of North America, 59(1), 75–88. https://doi.org/10.1016/j.pcl.2011.10.013

169.

Testa

Nuti

Hayek

De Felice

Chelli

Rovero

. . . Papini

A. M.

(2012). Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro, 4(4), Article AN20120015.

170.

Thayer

K. A.

Doerge

D. R.

Hunt

Schurman

S. H.

Twaddle

N. C.

Churchwell

M. I.

. . . Birnbaum

L. S.

(2015). Pharmacokinetics of bisphenol A in humans following a single oral administration. Environment International, 83, 107–115. https://doi.org/10.1016/j.envint.2015.06.008

171.

Thomas

Colborn

(1992). Organochlorine endocrine disruptors in human tissue. In Colborn

Clement

(Eds.), Chemically-induced alterations in sexual and functional development: the wildlife/human connection (pp. 365–394). Princeton Scientific Publishing Co., Inc.

172.

Tick

Bolton

Happé

Rutter

Rijsdijk

(2016). Heritability of autism spectrum disorders: A meta-analysis of twin studies. Journal of Child Psychology and Psychiatry, 57(5), 585–595.

173.

Tonacchera

Pinchera

Dimida

Ferrarini

Agretti

Vitti

. . . Gibbs

(2004). Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid, 14(12), 1012–1019.

174.

Tordjman

Somogyi

Coulon

Kermarrec

Cohen

Bronsard

. . . Lauth

(2014). Gene×environment interactions in autism spectrum disorders: Role of epigenetic mechanisms. Frontiers in Psychiatry, 5, Article 53.

175.

United Nations Environment Programme & World Health Organization. (2013). State of the science of endocrine disrupting chemicals–2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and World Health Organization (WHO) (Å. Bergman

Heindel

Jobling

Kidd

Zoeller

T. R.

, Eds.). WHO Press.

176.

United States Environmental Protection Agency. (2002). A review of the reference dose and reference concentration processes (No. EPA/630/P-02/002F). Risk Assessment Forum of the United States Environmental Protection Agency.

177.

United States Environmental Protection Agency. (2016). Limitations in the 1996 national-scale air toxics assessment. https://archive.epa.gov/airtoxics/nata/web/html/natsalim2.html

178.

United States Environmental Protection Agency. (2019). Endocrine disruption. https://www.epa.gov/endocrine-disruption

179.

Vandenberg

L. N.

(2012). State of the science in non-monotonic dose responses. In Workshop on Low Dose Effects and Non-monotonic Dose Responses for Endocrine Active Chemicals. European Commission’s Joint Research Centre’s Institute for Health and Consumer Protection (IHCP).

180.

Vandenberg

L. N.

Colborn

Hayes

T. B.

Heindel

J. J.

Jacobs

D. R.

Jr Lee

. . . vom Saal

F. S.

(2013). Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reproductive Toxicology, 38, 1–15.

181.

Vesterinen

H. M.

Johnson

P. I.

Atchley

D. S.

Sutton

Lam

Zlatnik

M. G.

. . . Woodruff

T. J.

(2015). Fetal growth and maternal glomerular filtration rate: A systematic review. The Journal of Maternal-Fetal & Neonatal Medicine, 28(18), 2176–2181.

182.

Viluksela

Raasmaja

Lebofsky

Stahl

B. U.

Rozman

K. K.

(2004). Tissue-specific effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on the activity of 5′-deiodinases I and II in rats. Toxicology Letters, 147(2), 133–142.

183.

Volk

H. E.

Hertz-Picciotto

Delwiche

Lurmann

McConnell

(2011). Residential proximity to freeways and autism in the CHARGE study. Environmental Health Perspectives, 119(6), 873–877. https://doi.org/10.1289/ehp.1002835

184.

Volk

H. E.

Lurmann

Penfold

Hertz-Picciotto

McConnell

(2013). Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry, 70(1), 71–77.

185.

von Ehrenstein

O. S.

Aralis

Cockburn

Ritz

(2014). In utero exposure to toxic air pollutants and risk of childhood autism. Epidemiology, 25(6), 851–858. https://doi.org/10.1097/EDE.0000000000000150

186.

Vrijheid

Casas

Gascon

Valvi

Nieuwenhuijsen

(2016). Environmental pollutants and child health—A review of recent concerns. International Journal of Hygiene and Environmental Health, 219(4–5), 331–342.

187.

Weber

Khan

Hollender

(2006). Human risk assessment of organic contaminants in reclaimed wastewater used for irrigation. Desalination, 187(1–3), 53–64.

188.

Weisskopf

M. G.

Webster

T. F.

(2017). Trade-offs of personal versus more proxy exposure measures in environmental epidemiology. Epidemiology, 28(5), 635–643. https://doi.org/10.1097/EDE.0000000000000686

189.

Welshons

W. V.

Nagel

S. C.

vom Saal

F. S.

(2006). Large effects from small exposures. III. endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology, 147(6), s56–s69.

190.

Williams

(2008). Neurodevelopmental and neurophysiological actions of thyroid hormone. Journal of Neuroendocrinology, 20(6), 784–794.

191.

Windham

G. C.

Sumner

S. X.

Anderson

Katz

Croen

L. A.

Grether

J. K.

(2013). Use of birth certificates to examine maternal occupational exposures and autism spectrum disorders in offspring. Autism Research, 6(1), 57–63.

192.

Windham

G. C.

Zhang

Gunier

Croen

L. A.

Grether

J. K.

(2006). Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay Area. Environmental Health Perspectives, 114(9), 1438–1444.

193.

Wolstenholme

J. T.

Edwards

Shetty

S. R.

Gatewood

J. D.

Taylor

J. A.

Rissman

E. F.

Connelly

J. J.

(2012). Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression. Endocrinology, 153(8), 3828–3838.

194.

Woodruff

T. J.

Sutton

(2014). The navigation guide systematic review methodology: A rigorous and transparent method for translating environmental health science into better health outcomes. Environmental Health Perspectives, 122(10), 1007–1014. https://doi.org/10.1289/ehp.1307175

195.

Woodruff

T. J.

Sutton

, & Navigation Guide Work Group. (2011). An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Affairs, 30(5), 931–937.

196.

Wang

Liu

Qin

Zhou

Wang

. . . Ma

(2014). Effects of tamoxifen on the sex determination gene and the activation of sex reversal in the developing gonad of mice. Toxicology, 321, 89–95.

197.

Zerbo

Qian

Yoshida

Fireman

B. H.

Klein

N. P.

Croen

L. A.

(2017). Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatrics, 171(1), Article e163609.

198.

Zhang

Dong

Ding

Qiao

Wang

Zhang

. . . Tang

(2014). Effects of n-butylparaben on steroidogenesis and spermatogenesis through changed E2 levels in male rat offspring. Environmental Toxicology and Pharmacology, 37(2), 705–717.

199.

Zhao

(2012). Development of a molecular biomarker for detecting intersex after exposure of male medaka fish to synthetic estrogen. Environmental Toxicology and Chemistry, 31(8), 1765–1773.

200.

Zoeller

R. T.

Brown

T. R.

Doan

L. L.

Gore

A. C.

Skakkebaek

Soto

. . . Vom Saal

(2012). Endocrine-disrupting chemicals and public health protection: A statement of principles from the endocrine society. Endocrinology, 153(9), 4097–4110.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB

0.02 MB

Systematic review of prenatal exposure to endocrine disrupting chemicals and autism spectrum disorder in offspring

Abstract

Lay abstract

Keywords

Get full access to this article

References

Supplementary Material